Another possibility is that the soft-agar assay measures AGR2-dependent biologies that are not captured in the other assays, a concept consistent with distinct breast cancer models, in which AGR2 overexpression was reported to play a role in metastases and adhesion, but not growth [11]. This evidence concerns the gene AGR2 and breast cancer.